Determinants of hospital costs in community-acquired pneumonia

European Respiratory Journal

Volumn 31, Issue 5, 2008, Pages 1061-1067

  Reyes, S ^a,b   Martinez, R ^a   Valles J M ^a   Cases, E ^a   Menendez, R ^a,c  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Centro de Investigación Biomédica en Red de Cáncer CIBERONC University of Barcelona   (Spain)

Author keywords

Community acquired pneumonia; Cost; Length of stay; Mortality; Pneumonia Severity Index; Treatment

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; COST OF ILLNESS; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL DISEASE; HOSPITAL COST; HUMAN; HYPOALBUMINEMIA; INFECTION; KIDNEY DISEASE; LABORATORY TEST; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; AGE; COMMUNICABLE DISEASE; ECONOMICS; HEALTH CARE COST; HOSPITALIZATION; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDY; SPAIN; UNIVERSITY HOSPITAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; HYPOALBUMINEMIA; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; SPAIN;

EID: 47049122882     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00083107     Document Type: Article

References (30)

1. Ambrosino N, Armaganidis A, Beurskens H. Pneumonia. In: European Respiratory/European Lung Foundation. European Lung White Book. The First Comprehensive Survey on Respiratory Health in Europe. Loddenkemper R, Gibson GJ, Sibille Y, eds. Sheffield, UK, ERSJ, 2003; pp. 55-65.
2. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-1754.
3. Fine MJ, Pratt HM, Obrosky DS, et al. Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia. Am J Med 2000; 109: 378-385.
4. Bauer TT, Welte T, Ernen C, et al. Cost analyses of community-acquired pneumonia from the hospital perspective. Chest 2005; 128: 2238-2246.
5. Masotti L, Ceccarelli E, Cappelli R, Barabesi L, Forconi S. Community-acquired pneumonia in elderly patients and length of hospitalization. Arch Intern Med 2000; 160: 2678-2679.
6. Menéndez R, Cremades MJ, Martinez-Moragón E, Soler JJ, Reyes S, Perpiñá M. Duration of length of stay in pneumonia: influence of clinical factors and hospital type. Eur Respir J 2003; 22: 643-648.
7. Bartolomé M, Almirall J, Morera J, et al. A population-based study of the costs of care for community-acquired pneumonia. Eur Respir J 2004; 23: 610-616.
8. González-Moraleja J, Sesma P, González C, López ME, Garcia JF, Alvarez-Sala JL. [What is the cost of inappropriate admission of pneumonia patients?]. Arch Bronconeumol 1999; 35: 312-316.
9. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
10. Torres A, Menéndez R. Mortality in COPD patients with community-acquired pneumonia: who is the third partner? Eur Respir J 2006; 28: 262-263.
11. Rhew DC, Tu GS, Ofman J, Henning JM, Richards MS, Weingarten SR. Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis. Arch Intern Med 2001; 161: 722-727.
12. Weingarten SR, Riedinger MS, Hobson P, et al. Evaluation of a pneumonia practice guideline in an interventional trial. Am J Respir Crit Care Med 1996; 153: 1110-1115.
13. Arancibia F, Ewig S, Martinez JA, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med 2000; 162: 154-160.
14. Fine MJ, Stone RA, Singer DE, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med 1999; 159: 970-980.
15. Diari Oficial de la Generalitat Valenciana. www.docv. gva.es/portal/portal/2002/12/31/pdf/doc/2002-14538.pdf Date last accessed: May 31, 2003. Date last updated: December 31, 2002.
16. Hosmer D, Lemeshow S, eds. Applied Logistic Regression. New York, John Wiley & Sons, 1989.
17. Monge V, San-Martin VM, González A. The burden of community-acquired pneumonia in Spain. Eur J Public Health 2001; 11: 362-364.
18. Monge V, González A. Hospital admissions for pneumonia in Spain. Infection 2001; 29: 3-6.
19. Guest JF, Morris A. Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur Respir J 1997; 10: 1530-1534.
20. Lave JR, Fine MJ, Sankey SS, Hanusa BH, Weissfeld LA, Kapoor WN. Hospitalized pneumonia. Outcomes, treatment patterns, and costs in urban and rural areas. J Gen Intern Med 1996; 11: 415-421.
21. Colice GL, Morley MA, Asche C, Birnbaum HG. Treatment costs of community-acquired pneumonia in an employed population. Chest 2004; 125: 2140-2145.
22. Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 2002; 165: 766-772.
23. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther 1998; 20: 820-837.
24. Rosón B, Carratalà J, Dorca J, Casanova A, Manresa F, Gudiol F. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis 2001; 33: 158-165.
25. Menéndez R, Torres A, Rodriguez de Castro F, et al. Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients. Clin Infect Dis 2004; 39: 1783-1790.
26. Riquelme R, Torres A, el-Ebiary M, et al. Community-acquired pneumonia in the elderly. Clinical and nutritional aspects. Am J Respir Crit Care Med 1997; 156: 1908-1914.
27. Cabré M, Serra-Prat M, Bolíbar I, Pallarés R. [Prognostic factors of community acquired pneumonia in very old patients.]. Med Clin (Barc) 2006; 127: 201-205.
28. Saldías Peñafiel F, O'Brien Solar A, Gederlini Gollerino A, Farías Gontupil G, Díaz Fuenzalida A. [Community-acquired pneumonia requiring hospitalization in immunocompetent elderly patients: clinical features, prognostic factors and treatment.]. Arch Bronconeumol 2003; 39: 333-340.
29. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: Suppl. 2, S27-S72.
30. Bont J, Hak E, Hoes AW, Schipper M, Schellevis FG, Verheij TJ. A prediction rule for elderly primary-care patients with lower respiratory tract infections. Eur Respir J 2007; 29: 969-975.